Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders

Sunday, Jan. 30th 2011 6:24 AM

Researchers at Children’s Hospital Boston have begun a randomized, placebo-controlled trial to test a potential drug treatment for Rett syndrome, the leading known genetic cause of autism in girls. The drug, mecasermin, a synthetic form of insulin-like growth factor-1 (IGF-1), is already FDA-approved for children with short stature due to IGF-1 deficiency.

VN:F [1.9.22_1171]
Rating: 5.0/5 (1 vote cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)
Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders, 5.0 out of 5 based on 1 rating
Posted on Sunday, Jan. 30th 2011 6:24 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply